Cleo Diagnostics Ltd has released a press release.
CLEO Delivers Commercial Development Milestone
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from CLEO Diagnostics
- Price Query Response
- CLEO Further Expands Ovarian Cancer Trial with Siles Health
- The Royal Women's Hospital Joins CLEO Ovarian Cancer Trial
- Cleo Commences U.S. Clinical Trials
- Appendix 4E and 2024 Annual Report
Later from CLEO Diagnostics
- CLEO Receives A$845k Research and Development Tax Incentive
- CLEO to Fast Track Development of Ovarian Cancer Test
- Cleo Advances with Completion of Alpha Testing
- Corporate Presentation
- CLEO Strengthens FDA Submission - Access to US Biobank
Follow CLEO Diagnostics into a list and get an email when it puts out news.
Follow CLEO Diagnostics